SOLICITATION NOTICE
T -- Consumer Education/Outreach Web Tool and Digital Video
- Notice Date
- 9/1/2009
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 512110
— Motion Picture and Video Production
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-09-1058874
- Point of Contact
- ZetherineGore, Phone: (301) 827-5093
- E-Mail Address
-
zetherine.gore@fda.hhs.gov
(zetherine.gore@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6, simplified acquisition procedures and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular 05-36. This announcement constitutes the only solicitation and a written solicitation will not be issued. This synopsis, NAICS code, 512110 is to notify contractors that the government intends to issue a Purchase Order in accordance with FAR Part 13.106 for the following statement of work, under the simplified acquisition procedures. This is a small business set-aside. Prospective offerors are responsible for downloading the solicitation and any amendments. It is the offeror's responsibility to monitor the FedBizOpps website for the release of any amendments to this solicitation. The Government reserves the right to award a contract without discussions if the Contracting Officer determines that the initial offer(s) is/are providing the Best Value and discussions are not necessary. This solicitation is issued as Request for Quote (RFQ) FDA-09-1058874. The Food and Drug Administration (FDA) intends to award a purchase order for Consumer Education Outreach Web Tool and Digital Video. 1. PROJECT TITLE: Consumer Education/Outreach Web Tool and Digital Video 2. STATEMENT OF WORK a. Background The Food and Drug Administration’s (FDA), Division of New Drugs and Labeling Compliance (DNDLC) is responsible for compliance and enforcement issues related to approval and labeling requirements for Over-the-Counter (OTC) and prescription drugs. DNDLC’s main responsibilities include enforcing the misbranding and new drugs provisions of the Federal Food, Drug, and Cosmetic Act (Act) for these drug products. The Act generally requires that drugs marketed in the United States be shown to be both safe and effective prior to marketing and widespread use in the general population. The drug approval process established by the FDA provides a review of product-specific information that is critical to ensuring the safety and efficacy of a finished drug product. Drugs marketed without required FDA approval may not meet modern standards for safety, effectiveness, quality, and labeling. The lacks of evidence demonstrating unapproved drugs are safe and effective is a significant public health concern. Over the past two decades, the worldwide web has blossomed exponentially into a global phenomenon. Along with that, the growth of the internet and its convenience of use allow for ease of commerce in marketing products to consumers. Consumers are increasingly utilizing the internet to purchase products, including drugs. Some consumers falsely believe that products they purchase from official appearing websites must be safe and efficacious. Many may purchase drugs without consulting additional sources of information, such as the FDA’s homepage, about the risks of purchasing drugs over the internet. It has become clear that the internet poses unique enforcement challenges. Unapproved drugs, health fraud, counterfeited drugs and compounded drugs sold or marketed over the internet are vast, dynamic, and extremely challenging to regulate through the enforcement of the Act in protecting the public health. The number of these targets on the internet greatly exceeds our available resources and thus, it is impractical to take enforcement actions against all entities that sell or market these types of products over the internet. It is essential to take proactive measures in educating vulnerable consumers who would purchase drugs over the internet that could potentially cause them harm. Short of taking enforcement actions against all entities selling unapproved drugs, fraudulent drugs, counterfeited drugs and compounded drugs over the internet, educating consumers will have a tremendous impact on these potentially harmful and hazardous behaviors of buying drugs online without the knowledge that they can potentially be unsafe and ineffective. DNDLC seeks to enhance and augment its public education and outreach efforts by contracting with a firm that is capable of developing web tools and producing creative short-form downloadable and streaming digital videos for distributing across multiple platforms. b. Objectives – Task 1 – To develop an interactive web tool that provides an important, proactive communication mechanism to educate the public at large in alerting vulnerable consumers about the risks associated with the purchase and use of unapproved drugs, fraudulent drugs, counterfeited drugs and compounded drugs over the internet. Task 2 - To develop creative and eye-catching short, downloadable, and streaming digital videos that can be utilize as proactive messaging tools to educate the public at large in alerting vulnerable consumers about the risks associated with the purchase and use of unapproved drugs, fraudulent drugs, counterfeited drugs and compounded drugs over the internet. c. Description of Work/Requirements: Independently and not as an agent of the Government, the contractor shall furnish the necessary services and personnel, and otherwise do all things necessary for or incident to the performance of the work as described below. The contractor shall provide the full range of services involved in web tool design and development including various design principles and web development technology that is search engine friendly through the use of advance coding (e.g. XHTML, CSS, Flash, etc.) The contractor shall provide the full range of services involved in video production, including creative development, hiring camera crews, booking and shooting interviews, graphic design, transcription, and editing. d. Experience and Capability Requirements (1) The contractor must have experience in creating media/web tools to educate consumers on a variety of issues. (2) The contractor must have experience in crafting media on multi-platforms such as the internet. The communication firm must have experience with creating campaigns for consumer related public health issues. (3) The contractor firm must have in-house assets to create and produce a campaign to include creative services (writing/branding,) production services, editorial services, computer animation, etc. (4) The contractor must have experience in creating web tools and media that has the potential to be “viral” and watched by millions. 3. REPORTING REQUIREMENTS AND DELIVERABLE ITEMS The contractor shall provide monthly status reports on the accomplishment of specific activities each month and various stages of work in progress. Deliverables: (a) Weekly Progress Activity Report : Weekly progress/activity reports shall be brief reports in letter format and should include: 1) work accomplished during the period 2) planned activities for the upcoming period 3) description of any problems experienced during the week or anticipated in the upcoming period, solutions or recommended plan for addressing issues (if applicable) (b) Monthly Progress/Activity Report: Monthly progress/activity reports shall be brief reports in letter format and should include: 1) work accomplished during the period 2) planned activities for the upcoming period 3) description of any problems experienced during the month or anticipated in the upcoming period, solutions or recommended plan for addressing issues (if applicable) One copy of this report will go to the FDA/CDER Project Officer and one copy to the Contracting Officer within 7 days following the end of each calendar month. (c) Final Report This report shall include a summation of the work performed for the entire contract period of performance. One copy of this report will go to the FDA/CDER Project Officer and one copy to the Contracting Officer within 7 days following the end of each calendar month. Reports must be provided in Microsoft Word or Excel format and accompanied by an electronic version. 4. PERIOD OF PERFORMANCE: One Base (12 month) Year and four (12 month) option years. Anticipated base period: September 25, 2009 – September 24, 2010. 5. PRICING: The Offeror’s fixed price should be provided for one year and 4 option years. 6. EVALUATION CRITERIA FOR COMPETITIVE PROPOSALS DNDLC will evaluate proposals based on technical and price considerations. DNDLC intends to evaluate proposals and award the contract without discussions with contractors (other than discussions conducted for the purpose of clarifications.) However, DNDLC reserves the right to conduct discussions if later determined by the Contracting Officer to be necessary. Therefore, each initial offer should contain the contractor’s best terms from a cost or price and technical standpoint. One contractor will be selected for award on the basis of its proposal being the most advantageous to DNDLC, price and other factors considered. Each technical proposal will be evaluated qualitatively and categorized as “Outstanding,” “Better,” “Acceptable,” “Marginal,” or “Unacceptable” in relation to the evaluation factors set forth in this solicitation. The contractor shall provide a Technical and Price proposal as outlined: Technical Proposal – The contractor shall provide a complete and detailed technical proposal package outlining all items identified and clearly delineating each applicable area of work as a separately priced item. a) Written Presentation – Part of the evaluation will be based on the assessment of the contractor’s ability to meet the objectives. The contractor is encouraged to provide innovative approaches to providing creative web tools and digital videos to educate consumers. b) A brief narrative describing its approach to using creative web tools and digital video and examples of key products, strategies, or tactics to be employed. Past Performance – Past performance will be evaluated on the extent to which past performance reflects depth, relevancy, cost control, and quality of recent experience in performing the same or similar work. Contractors should provide a description of their qualifications, experience, and further describe any previous projects that were similar to that requested. All references should be current and within the last two years from the date of proposal submission, and include project title, contract number, name of point of contact (POC), POC telephone number, and POC e-mail address. Price Proposal – The contractors shall provide a complete and detailed price proposal. It should include all applicable costs/pricing clearly delineating the applicable tasks outlined in the technical proposal. 7. PAYMENT SCHEDULE: Payment will be made in equal monthly installments. 8. CCR: Vendors must be registered in the Central Contractor Register (CCR) prior to the award of a contract. You may register by going to www.ccr.gov. You will need your Dun & Bradstreet number and banking information. 9. QUESTIONS DEADLINE: All questions are to be submitted via email to zetherine.Gore@fda.hhs.gov no later than September 3, 2009 2:00pm EST. 10. OFFERS DUE: Proposals must be delivered no later than 2:00 p.m. local time on September 9th, 2009. Proposal submissions are restricted to a limit of thirteen (13) pages. Proposal must be submitted via e-mail to zetherine.gore@fda.hhs.gov. 11. PROVISIONS AND CLAUSES: The provision at FAR 52.212-1, Instructions to Offerors Commercial Items applies to this solicitation. The following agenda has been attached to this provision: None. Offerors shall include a completed copy of the provision at FAR 52.212-3, Offeror Representations and Certifications Commercial Items. The clause at FAR 52.212-4, Contract Terms and Conditions, Commercial Items applies to this acquisition. The following agenda has been attached to the clause: None. The clause at FAR 52.212-5 Contract Terms and Conditions Required to Implement Statues or Executive Orders, Commercial Items applies to this acquisition. The following FAR clauses cited are applicable: FAR 52.217-8, FAR 52.217-9, FAR 52.222-26, FAR 52.222-35, FAR 52.222-36, and FAR 52.232-33. Clauses and provisions are incorporated by reference and apply to this acquisition. No telephone calls will be accepted.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-09-1058874/listing.html)
- Record
- SN01935819-W 20090903/090902004540-e07b569ed4ead39f10613e8709559cad (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |